Lei Xu, Tao Zhang, Baojie Zhu, Honglin Tao, Yue Liu, Xianfeng Liu, Yi Zhang, Xianli Meng. Mitochondrial quality control disorder in neurodegenerative disorders: potential and advantages of traditional Chinese medicines[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101146
Citation:
Lei Xu, Tao Zhang, Baojie Zhu, Honglin Tao, Yue Liu, Xianfeng Liu, Yi Zhang, Xianli Meng. Mitochondrial quality control disorder in neurodegenerative disorders: potential and advantages of traditional Chinese medicines[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101146
Lei Xu, Tao Zhang, Baojie Zhu, Honglin Tao, Yue Liu, Xianfeng Liu, Yi Zhang, Xianli Meng. Mitochondrial quality control disorder in neurodegenerative disorders: potential and advantages of traditional Chinese medicines[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101146
Citation:
Lei Xu, Tao Zhang, Baojie Zhu, Honglin Tao, Yue Liu, Xianfeng Liu, Yi Zhang, Xianli Meng. Mitochondrial quality control disorder in neurodegenerative disorders: potential and advantages of traditional Chinese medicines[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101146
a State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China;
b College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China;
c School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China;
d Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Meishan, Sichuan, 620032, China
Funds:
This work was supported by the Natural Science Foundation of China (Grant No.: 82130113), the “Xinglin Scholars” Research Promotion Program of Chengdu University of Traditional Chinese Medicine, China (Program No.: ZDZX2022005), the China Postdoctoral Science Foundation (Grant No.: 2021MD703800), and the Science Foundation for Youths of Science & Technology Department of Sichuan Province, China (Grant No.: 2022NSFSC1449).
Mitochondrial quality control disorder in neurodegenerative disorders: Potential and advantages of traditional Chinese medicines Abstract Neurodegenerative disorders (NDDs) are prevalent chronic conditions characterized by progressive synaptic loss and pathological protein alterations. Increasing evidence suggested that mitochondrial quality control (MQC) serves as the key cellular process responsible for clearing misfolded proteins and impaired mitochondria. Herein, we provided a comprehensive analysis of the mechanisms through which MQC mediates the onset and progression of NDDs, emphasizing mitochondrial dynamic stability, the clearance of damaged mitochondria, and the generation of new mitochondria. In addition, traditional Chinese medicines (TCMs) and their active monomers targeting MQC in NDD treatment have been demonstrated. Consequently, we compiled the TCMs that show great potential in the treatment of NDDs by targeting MQC, aiming to offer novel insights and a scientific foundation for the use of MQC stabilizers in NDD prevention and treatment.